About Event
The 3rd Operationalise: Early Access Programmes Summit Europe remains the premier European forum dedicated to defining global regulations and sharing real-world case studies for Early Access Programmes. From exploring the potential of harmonized regulatory frameworks to delving into best practices for establishing robust forecasting models for proactive supply planning, and identifying the types of data that are optimal for research and compliance, this summit is essential for those looking to revolutionize their Early Access Programmes in 2024.
Featuring in-depth industry discussions and actionable case studies, this event offers a unique exploration of the most pressing topics and industry bottlenecks. Join the summit to:
Who Attends?
Heads of Managed / Early / Expanded / Pre-Approval Access, Named Patient, Compassionate Use, Medical Affairs, Medical Operations, Clinical Operations and Supply from large pharma, biotechs and patient advocates will be in the same room to discuss actionable methods to better operationalise access programmes.
What Your Peers Have to Say:
“It is a non-competitive intelligence forum between key stakeholders that share the common hope and dedicate their engagement to bring new treatment options and innovations for patients” -
“Anne Raimond, Global Evidence Generation Director Medical Affairs Oncology, Servier
“A great exchange from pharma, regulatory, patient organization and patient representatives stakeholders”
“Philipp Schlatter, Patient Access & Drug Supply, Community of Practice Leader, Roche
““There were presentations on a wide range of interesting topics. I also really enjoyed learning from other Pharma companies' experiences”
Monique Smith Senior Manager, Medical Affairs Research, Vertex Pharmaceuticals